An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

Cancer Gene Therapy
A E RiceF R Jones

Abstract

We have investigated if immunotherapy against human papilloma virus (HPV) using a viral gene delivery platform to immunize against HPV 16 genes E6 and E7 (Ad5 [E1-, E2b-]-E6/E7) combined with programmed death-ligand 1 (PD-1) blockade could increase therapeutic effect as compared to the vaccine alone. Ad5 [E1-, E2b-]-E6/E7 as a single agent induced HPV-E6/E7 cell-mediated immunity. Immunotherapy using Ad5 [E1-, E2b-]-E6/E7 resulted in clearance of small tumors and an overall survival benefit in mice with larger established tumors. When immunotherapy was combined with immune checkpoint blockade, an increased level of anti-tumor activity against large tumors was observed. Analysis of the tumor microenvironment in Ad5 [E1-, E2b-]-E6/E7 treated mice revealed elevated CD8(+) tumor infiltrating lymphocytes (TILs); however, we observed induction of suppressive mechanisms such as programmed death-ligand 1 (PD-L1) expression on tumor cells and an increase in PD-1(+) TILs. When Ad5 [E1-, E2b-]-E6/E7 immunotherapy was combined with anti-PD-1 antibody, we observed CD8(+) TILs at the same level but a reduction in tumor PD-L1 expression on tumor cells and reduced PD-1(+) TILs providing a mechanism by which combination therapy favors a tumor c...Continue Reading

References

Jan 1, 1989·Cancer Chemotherapy and Pharmacology·M M Tomayko, C P Reynolds
Aug 31, 2001·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C E DemeureF Triebel
Jan 29, 2002·Gynecologic Oncology·Janet R DalingHisham Tamimi
Sep 5, 2002·European Journal of Immunology·Creg J WorkmanDario A A Vignali
Oct 8, 2003·Critical Reviews in Oral Biology and Medicine : an Official Publication of the American Association of Oral Biologists·Kalpana DevarajT-C Wu
Apr 22, 2004·The Journal of Immunology : Official Journal of the American Association of Immunologists·Creg J WorkmanDario A A Vignali
Oct 16, 2004·Immunity·Ching-Tai HuangDario A A Vignali
Mar 9, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Stina Syrjänen
Mar 18, 2005·Annual Review of Immunology·Rebecca J GreenwaldArlene H Sharpe
Dec 22, 2007·Nature Clinical Practice. Oncology·Amanda Psyrri, Daniel DiMaio
Feb 22, 2008·Proceedings of the National Academy of Sciences of the United States of America·F Stephen HodiGlenn Dranoff
May 27, 2008·Nature Reviews. Immunology·Weiping Zou, Lieping Chen
Dec 17, 2008·Archives of Otolaryngology--head & Neck Surgery·Dong Wook LeeJohn H Lee
Aug 12, 2009·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Betty LiKarin Jooss
Sep 3, 2009·Expert Review of Vaccines·Archana MonieT-C Wu
Feb 18, 2010·Proceedings of the National Academy of Sciences of the United States of America·Michael A CurranJames P Allison
Apr 14, 2010·Proceedings of the National Academy of Sciences of the United States of America·Junko MatsuzakiKunle Odunsi
May 11, 2010·The Lancet Oncology·Shanthi MarurArlene A Forastiere
Jun 8, 2010·The New England Journal of Medicine·F Stephen HodiWalter J Urba
Jun 10, 2010·The New England Journal of Medicine·K Kian AngMaura L Gillison
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Jan 24, 2013·The Open Virology Journal·Kei KawanaTomoyuki Fujii
Jun 4, 2013·The New England Journal of Medicine·Omid HamidAntoni Ribas
Jun 4, 2013·The New England Journal of Medicine·Jedd D WolchokMario Sznol
Jun 6, 2013·Nature Reviews. Clinical Oncology·Matti Lehtinen, Joakim Dillner
Dec 18, 2013·Vaccine·F Xavier BoschUNKNOWN authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012

❮ Previous
Next ❯

Citations

Feb 24, 2016·Expert Review of Vaccines·Andrew YangChien-Fu Hung
Mar 25, 2016·Expert Opinion on Biological Therapy·Julius StraussJames L Gulley
Apr 26, 2016·The Cancer Journal·Pavlos Msaouel, Erminia Massarelli
Jun 29, 2016·Clinical & Translational Immunology·Italia GrengaJeffrey Schlom
Aug 30, 2016·CA: a Cancer Journal for Clinicians·Fernanda G HerreraGeorge Coukos
Jun 27, 2018·Journal of Investigative Medicine : the Official Publication of the American Federation for Clinical Research·Bachar SamraIuliana Shapira
Nov 1, 2018·Annual Review of Medicine·Michael A Curran, Bonnie S Glisson
Nov 23, 2018·Cancer Immunology, Immunotherapy : CII·Amrita SinghToos Daemen
Jan 13, 2017·Oncotarget·Carolyn E BanisterPhillip J Buckhaults
Jun 20, 2020·Journal of Leukocyte Biology·Sohini RoyDouglas B Johnson
Apr 25, 2017·Nature Nanotechnology·Min LuoJinming Gao
Jul 2, 2019·Frontiers in Immunology·Xiangfeng ShenZhi-Xiang Xu
Mar 29, 2020·Molecular Carcinogenesis·Shira Tabachnick-ChernyPaul Nghiem
Oct 8, 2020·Current Treatment Options in Oncology·Lennox Chitsike, Penelope Duerksen-Hughes
Oct 20, 2020·Frontiers in Immunology·Xin-Wei QiaoYa-Ling Tang
Jul 16, 2019·Cancer Treatment Reviews·Takeo ShibataMayumi Nakagawa
Jul 17, 2019·Papillomavirus Research·Ian H Frazer, Janin Chandra
Dec 18, 2020·Frontiers in Immunology·Muhammad KhanGuixiang Liao
Feb 19, 2021·Frontiers in Immunology·Samuel I KimKatelyn T Byrne
Jun 4, 2021·Expert Opinion on Pharmacotherapy·Adam J Donne, Andy Kinshuck
Jun 3, 2021·Cancers·Kazuhiko MatsuoTakashi Nakayama
Aug 8, 2021·International Journal of Molecular Sciences·Chang-Gon KimHong-Jae Chon
Apr 24, 2021·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Louise FerrallT-C Wu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.